Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. (Q45945230)
Jump to navigation
Jump to search
scientific article published on 20 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. |
scientific article published on 20 October 2014 |
Statements
1 reference
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. (English)
1 reference
1 reference
1 reference
Seock-Ah Im
1 reference
José Baselga
1 reference
Emma Clark
1 reference
Graham Ross
1 reference
Astrid Kiermaier
1 reference
20 October 2014
1 reference
1 reference
32
1 reference
3753-3761
1 reference
33
1 reference
Identifiers
1 reference
1 reference